biotin has been researched along with prostaglandin a2 in 1 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (prostaglandin a2) | Trials (prostaglandin a2) | Recent Studies (post-2010) (prostaglandin a2) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 163 | 0 | 10 |
| Protein | Taxonomy | biotin (IC50) | prostaglandin a2 (IC50) |
|---|---|---|---|
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 13.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Fan, J; Gorospe, M; Lal, A; Wang, W; Yang, D; Yang, X | 1 |
1 other study(ies) available for biotin and prostaglandin a2
| Article | Year |
|---|---|
Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR.
Topics: 3' Untranslated Regions; Antigens, Surface; Biotin; Blotting, Northern; Blotting, Western; Calcium; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cross-Linking Reagents; Cyclin-Dependent Kinase Inhibitor p21; Cytoplasm; Dactinomycin; DNA, Complementary; Dose-Response Relationship, Drug; ELAV Proteins; ELAV-Like Protein 1; Enzyme Inhibitors; Humans; Immunoprecipitation; Kinetics; Mitogen-Activated Protein Kinase 3; Prostaglandins A; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Ultraviolet Rays | 2004 |